|
Market Closed -
Nasdaq
21:00:00 19/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 26.14 USD | +1.04% |
|
-2.32% | -2.39% |
| 08-18 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 08-07 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
| Market Cap | 1.11B 991M 918M 835M 1.57B 105B 1.59B 11.01B 4.33B 55.1B 4.17B 4.08B 176B | P/E 2026 * |
12x | P/E 2027 * | 9.9x |
|---|---|---|---|---|---|
| Enterprise Value | 1.42B 1.26B 1.17B 1.06B 1.99B 134B 2.03B 14.02B 5.51B 70.14B 5.31B 5.2B 224B | EV / Sales 2026 * |
1.89x | EV / Sales 2027 * | 1.65x |
| Free-Float |
47.23% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMPH | Delayed | |
CBOE
| AMPH | Real-time | |
Tradegate
| 29A | Real-time | |
Deutsche Boerse AG
| 29A | Delayed | |
Börse Stuttgart
| 29A | Delayed | |
Boerse Muenchen
| 29A | Real-time |
Last Transcript: Amphastar Pharmaceuticals, Inc.
| 1 day | +1.04% | ||
| 1 week | -2.32% | ||
| Current month | +1.28% | ||
| 1 month | +10.67% | ||
| 3 months | +32.39% | ||
| 6 months | +14.25% | ||
| Current year | -2.39% |
| 1 week | 25.52 | 27.1 | |
| 1 month | 23.45 | 27.8 | |
| Current year | 16.64 | 29.52 | |
| 1 year | 16.64 | 29.52 | |
| 3 years | 16.64 | 65.92 | |
| 5 years | 16.64 | 67.66 | |
| 10 years | 12.05 | 67.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Feng Zhang
CEO | Chief Executive Officer | 79 | 28/02/1996 |
Zi Ping Luo
COO | Chief Operating Officer | 76 | 28/02/1996 |
William Peters
DFI | Director of Finance/CFO | 58 | 31/03/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Zi Ping Luo
CHM | Chairman | 76 | 28/02/1996 |
Yong Feng Zhang
BRD | Director/Board Member | 79 | 28/02/1996 |
William Peters
BRD | Director/Board Member | 58 | 03/08/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/09/26 | Sell | Chief Financial Officer | -4,139 | 0.0097% | ||
| 16/09/26 | Exercice | Chief Technology Officer | 30,000 | 0.0705% | ||
| 02/09/26 | Sell | Chief Technology Officer | -3,187 | 0.0075% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.04% | -2.32% | +9.92% | -41.69% | 1.11B | ||
| -1.33% | +4.88% | +54.50% | +109.94% | 1,106B | ||
| -0.69% | -3.77% | +31.35% | +66.62% | 612B | ||
| -0.96% | +0.55% | +23.13% | +94.26% | 500B | ||
| +1.45% | +7.34% | +37.39% | +61.59% | 367B | ||
| -1.59% | -1.25% | +69.39% | +43.02% | 354B | ||
| +0.89% | +5.16% | +20.47% | +47.95% | 286B | ||
| +0.38% | +4.71% | -0.86% | +19.42% | 256B | ||
| -1.75% | +1.76% | +42.21% | +51.44% | 230B | ||
| -2.00% | +1.75% | +24.64% | +95.14% | 190B | ||
| Average | +0.46% | +1.63% | +31.21% | +54.77% | 390.13B | |
| Weighted average by Cap. | +0.77% | +2.30% | +38.28% | +75.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 748M 667M 617M 561M 1.05B 70.89B 1.07B 7.41B 2.91B 37.05B 2.81B 2.75B 118B | 784M 699M 648M 589M 1.11B 74.37B 1.12B 7.77B 3.05B 38.87B 2.94B 2.88B 124B |
| Net income | 99.32M 88.53M 82.01M 74.57M 140M 9.42B 142M 984M 387M 4.92B 373M 365M 15.73B | 115M 103M 95.31M 86.66M 163M 10.94B 165M 1.14B 450M 5.72B 433M 424M 18.28B |
| Net Debt | 303M 270M 251M 228M 427M 28.77B 435M 3.01B 1.18B 15.04B 1.14B 1.11B 48.06B | 184M 164M 152M 138M 259M 17.46B 264M 1.82B 717M 9.12B 691M 676M 29.17B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/10/26 | US$26.14 | +1.04% | 299,510 |
| 16/10/26 | US$25.87 | -2.08% | 352,084 |
| 15/10/26 | US$26.42 | +1.30% | 352,436 |
| 14/10/26 | US$26.08 | +0.12% | 364,655 |
| 13/10/26 | US$26.05 | -2.65% | 326,547 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMPH Stock
Select your edition
All financial news and data tailored to specific country editions

















